Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brooks

Showing results (901-910 of 928) with videos related to

Pageof 93
Sort By:
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Age and the Diurnal Oscillatory Features of the Human ChronobiomeCarsten Skarke, Nicholas F Lahens, Antonijo Mrčela, et al.
Cell|December 22, 2015
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN SignalingAutumn G York, Kevin J Williams, Joseph P Argus, et al.
Plos Medicine|April 20, 2016
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialJake Dunning, Foday Sahr, Amanda Rojek, et al.
Nature Immunology|July 14, 2022
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapyGiselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, et al.
American Journal of Human Genetics|September 16, 1999
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypesS Annunen, J Körkkö, M Czarny, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancerStephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.
Nature Nanotechnology|April 22, 2022
Single-crystalline TiO<sub>2</sub> nanoparticles for stable and efficient perovskite modulesYong Ding, Bin Ding, Hiroyuki Kanda, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Communications|August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivityS Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Pageof 93

Showing results (901-910 of 928) with videos related to

Sort By:
Pageof 93
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Age and the Diurnal Oscillatory Features of the Human ChronobiomeCarsten Skarke, Nicholas F Lahens, Antonijo Mrčela, et al.
Cell|December 22, 2015
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN SignalingAutumn G York, Kevin J Williams, Joseph P Argus, et al.
Plos Medicine|April 20, 2016
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialJake Dunning, Foday Sahr, Amanda Rojek, et al.
Nature Immunology|July 14, 2022
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapyGiselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, et al.
American Journal of Human Genetics|September 16, 1999
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypesS Annunen, J Körkkö, M Czarny, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancerStephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.
Nature Nanotechnology|April 22, 2022
Single-crystalline TiO<sub>2</sub> nanoparticles for stable and efficient perovskite modulesYong Ding, Bin Ding, Hiroyuki Kanda, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Communications|August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivityS Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Pageof 93